Taray, Sappari A.

HRN: 04-17-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/25/2026
03/04/2026
IVTT
500mg
Q8
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: